Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling

Identifieur interne : 006247 ( Main/Repository ); précédent : 006246; suivant : 006248

Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling

Auteurs : RBID : Pascal:08-0527236

Descripteurs français

English descriptors

Abstract

Background-Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium 111In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. Methods and Results-Left common carotid artery injury was induced with a guidewire in apolipoprotein E-/- mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E-/- mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001). Conclusions-Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:08-0527236

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling</title>
<author>
<name>JIASHENG ZHANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name>LEI NIE</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Razavian, Mahmoud" uniqKey="Razavian M">Mahmoud Razavian</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ahmed, Masood" uniqKey="Ahmed M">Masood Ahmed</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dobrucki, Lawrence W" uniqKey="Dobrucki L">Lawrence W. Dobrucki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Asadi, Abolfazl" uniqKey="Asadi A">Abolfazl Asadi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Edwards, D Scott" uniqKey="Edwards D">D. Scott Edwards</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Lantheus Medical Imaging</s1>
<s2>North Billerica, Mass</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Lantheus Medical Imaging</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Azure, Michael" uniqKey="Azure M">Michael Azure</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Lantheus Medical Imaging</s1>
<s2>North Billerica, Mass</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Lantheus Medical Imaging</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sinusas, Albert J" uniqKey="Sinusas A">Albert J. Sinusas</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sadeghi, Mehran M" uniqKey="Sadeghi M">Mehran M. Sadeghi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="inist">08-0527236</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0527236 INIST</idno>
<idno type="RBID">Pascal:08-0527236</idno>
<idno type="wicri:Area/Main/Corpus">005F96</idno>
<idno type="wicri:Area/Main/Repository">006247</idno>
</publicationStmt>
<seriesStmt>
<idno type="ISSN">0009-7322</idno>
<title level="j" type="abbreviated">Circulation : (N. Y. N.Y.)</title>
<title level="j" type="main">Circulation : (New York, N.Y.)</title>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cardiovascular disease</term>
<term>Molecular imaging</term>
<term>Vascular remodeling</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Pathologie de l'appareil circulatoire</term>
<term>Remodelage vasculaire</term>
<term>Imagerie moléculaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background-Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium
<sup>111</sup>
In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. Methods and Results-Left common carotid artery injury was induced with a guidewire in apolipoprotein E
<sup>-/-</sup>
mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E
<sup>-/-</sup>
mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001). Conclusions-Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0009-7322</s0>
</fA01>
<fA02 i1="01">
<s0>CIRCAZ</s0>
</fA02>
<fA03 i2="1">
<s0>Circulation : (N. Y. N.Y.)</s0>
</fA03>
<fA05>
<s2>118</s2>
</fA05>
<fA06>
<s2>19</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>JIASHENG ZHANG</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>LEI NIE</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>RAZAVIAN (Mahmoud)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>AHMED (Masood)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>DOBRUCKI (Lawrence W.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>ASADI (Abolfazl)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>EDWARDS (D. Scott)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>AZURE (Michael)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>SINUSAS (Albert J.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>SADEGHI (Mehran M.)</s1>
</fA11>
<fA14 i1="01">
<s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Lantheus Medical Imaging</s1>
<s2>North Billerica, Mass</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA20>
<s1>1953-1960</s1>
</fA20>
<fA21>
<s1>2008</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>5907</s2>
<s5>354000184333010070</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>39 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>08-0527236</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Circulation : (New York, N.Y.)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background-Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium
<sup>111</sup>
In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. Methods and Results-Left common carotid artery injury was induced with a guidewire in apolipoprotein E
<sup>-/-</sup>
mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E
<sup>-/-</sup>
mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001). Conclusions-Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B12B03</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B02G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Remodelage vasculaire</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Vascular remodeling</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Remodelado vascular</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Imagerie moléculaire</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Molecular imaging</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fN21>
<s1>343</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV3/Data/Main/Repository
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006247 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Repository/biblio.hfd -nk 006247 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV3
   |flux=    Main
   |étape=   Repository
   |type=    RBID
   |clé=     Pascal:08-0527236
   |texte=   Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
}}

Wicri

This area was generated with Dilib version V0.5.77.
Data generation: Mon Jun 9 10:27:54 2014. Site generation: Thu Mar 7 16:19:59 2024